Sign In
Samples
/
Stelara
Immunology
Stelara
ustekinumab
Manufacturer
Janssen (J&J)
Indication
IL-12/23 inhibitor for psoriasis, PsA, Crohns, UC
Sample Info:
Unbranded biologic approved April 2025.
Check My Eligibility
How It Works
1
Enter your NPI number and email address
2
We check your eligibility with Janssen (J&J)
3
Order samples instantly or request access
Free for healthcare providers
350K+ providers use PrescriberPoint
More from Janssen (J&J)
View all
Xarelto
rivaroxaban
Cardiovascular
Darzalex
daratumumab
Oncology
Tremfya
guselkumab
Dermatology
Erleada
apalutamide
Oncology
Spravato
esketamine
Psychiatry
Invega Sustenna
paliperidone palmitate
Psychiatry
More Immunology Samples
View all
Dupixent
dupilumab
Sanofi
Skyrizi
risankizumab
AbbVie
Humira
adalimumab
AbbVie
Cosentyx
secukinumab
Novartis
Rinvoq
upadacitinib
AbbVie
Enbrel
etanercept
Amgen
Popular Samples
Browse all
Ozempic
semaglutide injection
Novo Nordisk
Diabetes
Eliquis
apixaban
Pfizer
Cardiovascular
Keytruda
pembrolizumab
Merck
Oncology
Eylea
aflibercept
Regeneron
Ophthalmology
Entresto
sacubitril/valsartan
Novartis
Cardiovascular
105+
Products Available
50+
Manufacturers
20+
Therapeutic Areas
Stelara (ustekinumab) Drug Samples | PrescriberPoint | PrescriberPoint